Business
Biogen's CEO Will Depart and the Biotech Company is Planning More Deep Cost Cuts as It ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Biogen's CEO will depart and the biotech company is planning more deep cost cuts as it tries to move beyond a disastrous rollout for its Alzheimer’s disease drug Aduhelm ...'
Biogen's CEO will depart and the biotech company is planning more deep cost cuts as it tries to move beyond a disastrous rollout for its Alzheimer’s disease drug Aduhelm https://t.co/QtCxJfB8Tf— Bloomberg (@business) May 3, 2022
(The above story first appeared on LatestLY on May 03, 2022 10:24 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
